Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Molecular Oncology|July 28, 2023
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancerOfra Novoplansky, Avital B Shnerb, Divyasree Marripati, et al.Cancers|April 12, 2022
Unmet Needs and Perspectives in Oral Cancer PreventionJebrane Bouaoud, Paolo Bossi, Moshe Elkabets, et al.International Journal of Molecular Medicine|March 4, 2016
Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in miceShirin Elhaik Goldman, Shahar Dotan, Amir Talias, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 19, 2024
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for GlioblastomaXin Peng, Xin Huang, Shaolu Zhang, et al.Neoplasia (New York, N.Y.)|March 21, 2025
Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancersDinesh Babu Manikandan, Sankar Jagadeeshan, Sooraj Mathukkada, et al.Cell Death & Disease|October 16, 2025
Pharmacological activation of SIRT6 suppresses progression of head and neck and esophageal squamous cell carcinoma by modulation of cellular metabolism and protein translationTalal Ben Lulu, Dinesh Babu Manikandan, Yaniv Pevzner, et al.NPJ Precision Oncology|May 23, 2024
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancerThomas F Cyberski, Alka Singh, Michael Korzinkin, et al.Advanced Materials (Deerfield Beach, Fla.)|May 10, 2025
Mechanostimulatory Platform for Improved CAR T Cell ImmunotherapyAbed Al-Kader Yassin, Carlos Ureña Martin, Guillaume Le Saux, et al.Science Translational Medicine|August 2, 2013
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancerMoshe Elkabets, Sadhna Vora, Dejan Juric, et al.Oral Oncology|January 14, 2024
Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinomaSankar Jagadeeshan, Kushal Suryamohan, Nara Shin, et al.Pageof 9